Swiss health tech company Sophia Genetics lands $30 mln Series D

Sophia Genetics, a Swiss health tech company, has secured $30 million in Series D funding. Balderton Capital led the round with participation from 360º Capital Partners, Invoke Capital and Alychlo.

Source: Press Release

Find new deal opportunities, super-charge your fundraising efforts and track top managers with VCJ. Get your FREE trial! Or subscribe now!